DP

Diadema Partners Portfolio holdings

AUM $161M
This Quarter Return
+3.6%
1 Year Return
3 Year Return
5 Year Return
10 Year Return
AUM
$88.7M
AUM Growth
Cap. Flow
+$88.7M
Cap. Flow %
100%
Top 10 Hldgs %
58.9%
Holding
86
New
54
Increased
Reduced
Closed

Top Sells

No sells this quarter

Sector Composition

1 Healthcare 100%
2 Utilities 0%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
MNMD icon
51
MindMed
MNMD
$702M
$32.8K 0.01%
+4,710
New +$32.8K
LVTX icon
52
LAVA Therapeutics
LVTX
$41.3M
$20.5K 0.01%
+21,508
New +$20.5K
APVO icon
53
Aptevo Therapeutics
APVO
$5.29M
$17.5K 0.01%
+203
New +$17.5K
LRMR icon
54
Larimar Therapeutics
LRMR
$337M
$14.7K 0.01%
+3,800
New +$14.7K
AGIO icon
55
Agios Pharmaceuticals
AGIO
$2.09B
0
ALT icon
56
Altimmune
ALT
$334M
0
ANAB icon
57
AnaptysBio
ANAB
$613M
0
APLS icon
58
Apellis Pharmaceuticals
APLS
$3.55B
0
ARVN icon
59
Arvinas
ARVN
$575M
0
JBIO
60
Jade Biosciences, Inc. Common Stock
JBIO
$254M
0
BBIO icon
61
BridgeBio Pharma
BBIO
$10.2B
0
BHVN icon
62
Biohaven
BHVN
$1.68B
0
BMEA icon
63
Biomea Fusion
BMEA
$114M
0
CAPR icon
64
Capricor Therapeutics
CAPR
$308M
0
CCCC icon
65
C4 Therapeutics
CCCC
$194M
0
CLDX icon
66
Celldex Therapeutics
CLDX
$1.52B
0
CRSP icon
67
CRISPR Therapeutics
CRSP
$4.99B
0
FOLD icon
68
Amicus Therapeutics
FOLD
$2.46B
0
HALO icon
69
Halozyme
HALO
$8.76B
0
IOVA icon
70
Iovance Biotherapeutics
IOVA
$901M
0
JANX icon
71
Janux Therapeutics
JANX
$1.44B
0
KOD icon
72
Kodiak Sciences
KOD
$556M
0
LXRX icon
73
Lexicon Pharmaceuticals
LXRX
$396M
0
NMRA icon
74
Neumora Therapeutics
NMRA
$272M
0
OCUL icon
75
Ocular Therapeutix
OCUL
$2.37B
0